SCHEMBL12377822

SCHEMBL12377822

CCn1nc(-c2cccc(C)c2)oc1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IL2 P60568 1/20 0.49
NOTUM Q6P988 1/20 0.49
NPC1 O15118 5/20 0.46
HPGD P15428 4/20 0.46
RAB9A P51151 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
TSHR P16473 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
GRIN1 Q05586 1/20 0.45
GRIN2B Q13224 1/20 0.45
GAA P10253 1/20 0.42
ALDH1A1 P00352 2/20 0.42
TP53 P04637 2/20 0.42
HSD17B10 Q99714 2/20 0.42
POLB P06746 1/20 0.42
KDM4E B2RXH2 3/20 0.42
PBRM1 Q86U86 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12377829 0.85 GRIN1 (0.47) IL2NOTUMNPC1HPGDRAB9A
SCHEMBL12377825 0.85 GRIN1 (0.47) IL2NOTUMNPC1HPGDRAB9A
SCHEMBL12377830 0.83 NOTUM (0.45) IL2NOTUMNPC1HPGDRAB9A
SCHEMBL12377833 0.83 GAA (0.47) IL2NOTUMNPC1HPGDRAB9A
SCHEMBL10703697 0.83 KDM4E (0.51) HPGDSMN1; SMN2GRIN1GRIN2BGAA
SCHEMBL12377824 0.82 NOTUM (0.47) NOTUMNPC1HPGDRAB9ASMN1; SMN2
SCHEMBL12377828 0.82 GRIN1 (0.46) IL2NOTUMNPC1HPGDRAB9A
SCHEMBL9186057 0.81 NOTUM (0.43) IL2NOTUMNPC1HPGDRAB9A
SCHEMBL12377835 0.80 GRIN2B (0.50) IL2NOTUMNPC1HPGDRAB9A
SCHEMBL12377836 0.80 GAA (0.45) IL2NOTUMNPC1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998954-B2 Pyrimidodiazepinone derivative KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-08-16 US disclosed
US-7998954-B2 Pyrimidodiazepinone derivative KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-08-16 US disclosed
US-20100190775-A1 PYRIMIDODIAZEPINONE DERIVATIVE KYOWA HAKKO KIRIN CO., LTD (JP) 2010-07-29 US disclosed
US-20100190775-A1 PYRIMIDODIAZEPINONE DERIVATIVE KYOWA HAKKO KIRIN CO., LTD (JP) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190775-A1 PYRIMIDODIAZEPINONE DERIVATIVE KCNJ1, KCNJ11, ADRA1D IL2 2525/4885NOTUM 3182/4885NPC1 1132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.